Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
- Conditions
- Ductal Carcinoma in SituInvasive Lobular Breast Carcinoma
- Registration Number
- NCT06133647
- Lead Sponsor
- Methodist Health System
- Brief Summary
To determine the number of MBC cases as well as the demographics, characteristics, and outcomes of MBC patients at Methodist Health System (MHS).
- Detailed Description
Male breast cancer (MBC) is a rare disease without sufficient clinical data supporting the management and treatment. The treatment of MBC arises from data extrapolated from female breast cancer (FBC). MBC has higher mortality than FBC. Previous studies have suggested differences between MBC and FBC; however, treatments remain the same for both. Larger studies in MBC are needed to provide more clinical data to help guide treatment.
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 8
- • ≥ 18 years of age Patients diagnosed with ductal carcinoma in situ or invasive lobular carcinoma of the breast
-
18 years of age
- Prisoners
- Pregnant or breastfeeding
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determine the complications of Treatment in patients with MBC and FBC 13 years Determine the complications of Treatment in patients with MBC and FBC
Diagnosis Rates of patients with MBC and FBC 13 years complications of treatment
Recurrence rates of Patients with MBC and FBC 13 years Recurrence rates of Patients with MBC and FBC
Duration of remission in Patients with MBC and FBC 13 years Duration of remission in Patients with MBC and FBC
The Overall Survival of patients with MBC and FBC after receiving treatment 13 years The Overall Survival of patients with MBC and FBC after receiving treatment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Clinical Research Institute at Methodist Health System
🇺🇸Dallas, Texas, United States